Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (18 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net sales
2,470
2,478
2,464
2,591
2,656
Cost of products sold
1,855
1,894
1,810
1,910
1,915
Gross Profit
615
585
654
681
741
Marketing and selling expenses
172
170
176
177
177
Administrative expenses
80
89
120
117
107
Research and development expenses
8
12
11
11
13
Goodwill impairment charge
123
0
0
0
0
Termination fee received, net of costs, associated with the Hillshire merger agreement
0
0
0
-153
0
Other expense (income), net
49
30
55
16
19
Total operating expenses
432
301
361
169
316
Earnings before interest and taxes
183
284
293
512
425
Interest expense
208
198
132
96
89
Interest income
0
0
0
0
0
Earnings before income taxes
-25
85
161
416
336
Provision for income taxes
22
33
71
168
124
Net earnings
-47
53
89
248
213
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
92
117
38
181
Accounts receivable, net of allowances of $7,902 and $6,801, respectively
n/a
144
165
191
220
Inventories
n/a
358
362
356
403
Other current assets
n/a
12
8
8
14
Deferred tax assets
n/a
99
141
122
41
Total current assets
n/a
705
792
716
858
Plant assets, net of accumulated depreciation of $408,294 and $349,639, respectively
n/a
494
523
606
631
Tradenames
n/a
1,604
1,951
2,002
2,001
Other assets, net
n/a
156
186
158
120
Goodwill
n/a
1,441
1,628
1,720
1,714
Total assets
n/a
4,400
5,081
5,201
5,324
Liabilities and owners' equity
Short-term borrowings
n/a
2 2139000
2 2437000
2 2396000
2 2225000
Current portion of long-term obligations
n/a
30 30419000
25 24580000
12 11916000
15 14847000
Accounts payable
n/a
137 137326000
142 142353000
199 198579000
211 211039000
Accrued trade marketing expense
n/a
45 44571000
37 37060000
36 36210000
46 46228000
Accrued liabilities
n/a
119 119269000
100 99755000
106 106488000
101 100510000
Dividends payable
n/a
0 0
25 25119000
28 27847000
31 30798000
Total current liabilities
n/a
334 333724000
331 331304000
383 383436000
406 405647000
Long-term debt (includes $27,716 and $47,315 owed to related parties, respectively)
n/a
2,576 2576386000
2,476 2476167000
2,286 2285984000
2,257 2257012000
Pension and other postretirement benefits
n/a
101 100918000
50 49847000
62 61830000
63 63454000
Other long-term liabilities
n/a
29 28705000
25 24560000
34 34305000
55 54506000
Deferred tax liabilities
n/a
472 471529000
601 601272000
721 721401000
738 738015000
Total liabilities
n/a
3,511 3511262000
3,483 3483150000
3,487 3486956000
3,519 3518634000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
Pinnacle preferred stock: $.01 per share, 50,000,000 shares authorized, none issued
n/a
0 0
0 0
0 0
0 0
Pinnacle common stock: par value $.01 per share, 500,000,000 shares authorized; issued 117,619,695 and 117,293,745, respectively
n/a
1 812000
1 1172000
1 1173000
1 1176000
Additional paid-in-capital
n/a
697 696512000
1,329 1328847000
1,363 1363129000
1,379 1378521000
Retained earnings
n/a
253 252955000
276 275519000
420 419531000
517 517330000
Accumulated other comprehensive loss
n/a
-62 -61553000
-7 -7497000
-38 -37734000
-59 -59388000
Capital stock in treasury, at cost, 1,000,000 common shares
n/a
0 0
0 0
-32 -32110000
-32 -32110000
Total shareholders' equity
n/a
889 888726000
1,598 1598041000
1,714 1713989000
1,806 1805529000
Non-controlling interest
n/a
0 0
0 0
0 0
0 0
Total equity
n/a
0 0
0 0
0 0
1,806 1805529000
Total liabilities and shareholders' equity
n/a
4,400 4399988000
5,081 5081191000
5,201 5200945000
5,324 5324163000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Jul 29, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (50 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net earnings
-47
53
89
248
213
Depreciation and amortization
88
98
78
81
90
Amortization of debt acquisition costs and discount on term loan
11
9
4
4
4
Goodwill and intangible asset impairment charge
148
1
0
0
0
Plant asset impairment charge
1
0
0
0
0
Amortization of discount on term loan
1
1
1
2
2
Call premium on note redemptions
0
14
34
0
0
Refinancing costs and write off of debt issuance costs
0
17
20
2
0
Amortization of deferred mark-to-market adjustment on terminated swaps
2
0
0
0
0
Change in value of financial instruments
2
-1
-1
13
-2
Equity based compensation expense
1
1
8
36
15
Pension expense, net of contributions
-14
-10
-9
-9
-5
Gain on sale of assets held for sale
0
0
-4
-2
0
Other long-term liabilities
0
3
-2
2
5
Other long-term assets
0
0
0
0
0
Foreign exchange losses
0
0
0
3
5
Deferred income taxes
21
31
68
160
116
Accounts receivable
-11
16
-21
-22
-31
Inventories
-6
-22
16
22
-49
Accrued trade marketing expense
-12
9
-7
-1
11
Accounts payable
38
-16
4
25
15
Accrued liabilities
-23
-1
-17
-12
-8
Other current assets
3
1
0
-1
-6
Net cash provided by operating activities
204
203
262
551
373
Business acquisition activity
0
0
-575
-169
1
Capital expenditures
-117
-78
-84
-103
-108
Proceeds from sale of plant assets
8
1
7
2
2
Net cash used in investing activities
-109
-78
-652
-270
-106
Net proceeds from issuance of common stock
1
0
625
0
1
Repurchases of equity
-2
-1
0
0
0
Dividends paid
0
0
-42
-102
-112
Proceeds from bank term loans
0
843
2,142
0
0
Proceeds from notes offerings
0
0
350
0
0
Repayments of long-term obligations
-58
-632
-1,736
-220
-9
Repurchase of notes
0
-373
-899
0
0
Proceeds from short-term borrowings
3
4
5
5
4
Repayments of short-term borrowings
-3
-4
-5
-5
-4
Borrowings under revolving credit facility
0
40
0
65
0
Repayments of revolving credit facility
0
-40
0
-65
0
Repayment of capital lease obligations
-3
-4
-3
-2
-4
Purchase of stock for treasury
0
0
0
-32
0
Excess tax benefits on stock-based compensation
0
0
0
1
1
Taxes paid related to net share settlement of equity awards
0
0
0
-3
-2
Debt acquisition costs
-1
-17
-23
0
0
Other financing
3
0
0
0
0
Net cash (used in) provided by financing activities
-59
-184
414
-358
-124
Effect of exchange rate changes on cash
0
0
0
-1
-1
Net change in cash and cash equivalents
36
-59
24
-78
142
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo